Matthew S. Krantz, MD, is an Instructor of Medicine in the Division of Allergy, Pulmonary, and Critical Care Medicine in the Department of Medicine at Vanderbilt University Medical Center. He has a secondary appointment in the Department of Biomedical Informatics.
Dr. Krantz received his MD from the University of North Carolina School of Medicine. He completed his residency in combined internal medicine and pediatrics and fellowship in allergy and immunology at VUMC, during which he participated in an NHLBI-funded T32 post-doctoral research training program. He is currently pursuing an MS in biomedical informatics at Vanderbilt University.
As an allergy and immunology physician-scientist, Dr. Krantz is interested in researching severe immune-mediated adverse drug reactions and other allergic/immunologic diseases by leveraging electronic health record phenotyping, immunogenomics, and translational bioinformatics in large electronic health record-linked biobanks.
He is a recipient of the 2024 AAAAI Foundation Faculty Development Award, which supports his research project, "A Translational Bioinformatics Approach for Deep Phenotyping and Genetic Risk of Severe Cutaneous Adverse Drug Reactions." His primary mentor is Dr. Elizabeth Phillips, an international expert in translational approaches for severe immune-mediated drug reactions and director of the Center for Drug Safety and Immunology.
Dr. Krantz sees patients in the Drug Allergy Clinic, which provides personalized testing and care for people with drug and medication allergies, part of the Vanderbilt Asthma, Sinus and Allergy Program.